[4] This makes logical sense given its mechanisms of action through multiple pathways, including enhanced GLP-1 secretion
Hussain et al., A Narrative Review of Approved and Emerging anti-obesity Medications , Saudi Pharmaceutical Journal vol
Efficacy and Safety of Semaglutide Compared with Liraglutide and Placebo for Weight Loss in Patients with Obesity: A Randomised, Double-blind, Placebo and Active Controlled, Dose-ranging, Phase 2 Trial. The Lancet, 390(10100), 898-907
Lets be realwho wouldnt want more energy and less stress
Most cases of semaglutide not working are actually dosing or titration issues Nearly half of GLP-1 patients stop at 180 days due to side effects (52%), supply issues (33%), and cost (25%) A 2025 study found patients seeing an obesity specialist were 8 times more likely to stick with GLP-1s Rivas Medical Weight Loss has been treating obesity since 1991
You can receive expert consultations and follow-ups through convenient virtual appointments from anywhere